DRUG · Mapped RxNorm record
Ephedrine
Normalized identity: ephedrineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
"Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat
NCT00377975
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Pioglitazone
Normalized identity: pioglitazoneView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Caffeine
Normalized identity: caffeineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backed"Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Obesityverified · MONDO: obesity disorder
Interventions
EphedrineDRUG · verified · RxNorm: ephedrine
PioglitazoneDRUG · verified · RxNorm: pioglitazone
CaffeineDRUG · verified · RxNorm: caffeine
Sponsors & collaborators
Pennington Biomedical Research Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00377975 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.